Plain-English translation of NCT06697600 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a decision-support tool called UR-GOAL designed specifically for older adults who have just been diagnosed with acute myeloid leukemia (AML). The tool helps patients, their caregivers, and doctors understand what matters most to the patient and work together to choose treatments that fit those priorities. The researchers believe this approach will reduce stress and help everyone feel more confident about treatment decisions.
When older adults are first diagnosed with AML, they face urgent and complex treatment decisions. Patients and their doctors don't always have clear conversations about what the patient values most or what realistic outcomes to expect. This trial exists to test whether giving doctors and patients better information upfront—through videos, questionnaires, and personalized summaries—leads to less anxiety and better shared decision-making.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either the main intervention group or a comparison group. In the main group, you'll watch an educational video about AML, complete a questionnaire about your priorities, and receive a personalized summary report to discuss with your doctor and caregiver. Your caregiver (if you have one) will also watch the video and receive the summary. Your oncologist will get a report that includes your priorities and medical background to guide your conversations. The comparison group will watch a nutrition video instead and discuss nutrition information with their care team. Throughout the study, you'll continue your regular clinical visits as planned.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States